Literature DB >> 1864539

Morphometric studies in rectal biopsy specimens from patients with ulcerative colitis: effect of oral 5 amino salicylic acid and rectal prednisolone treatment.

A M Zaitoun1, I Cobden, H al Mardini, C O Record.   

Abstract

Morphometric measurements were performed on rectal biopsy specimens from 10 normal control subjects and 33 patients with a relapse of distal ulcerative colitis before and after treatment for four weeks in a double blind controlled trial with oral eudragit S coated 5 amino salicylic acid (n = 12) or rectal prednisolone enemas (n = 15). Measurements were assessed using a computer aided measuring system and a counting technique. When untreated patients were compared with the control group there were significant decreases in the area and height of the surface epithelium, in the area of crypt epithelium, and in the ratios of goblet cells to epithelial cells and of surface epithelium to lamina propria. The vascular and lamina propria areas and the number of intraepithelial polymorphs were increased. Treatment with 5 amino salicylic acid and corticosteroids resulted in similar morphological improvements: there was an increase in the area and height of the surface epithelium and the ratios of surface epithelium to lamina propria and of surface to crypt cell height. The ratio of goblet cells to epithelial cells also increased after treatment, while the numbers of polymorphs in the surface and crypt epithelium and lumen decreased. In conclusion, computerised morphometry is valuable for the assessment of the treatment of patients with ulcerative colitis and that in the doses used both treatments were of similar efficacy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864539      PMCID: PMC1378805          DOI: 10.1136/gut.32.2.183

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Architectural morphometry in ulcerative colitis with dysplasia.

Authors:  D C Allen; P W Hamilton; P C Watt; J D Biggart
Journal:  Histopathology       Date:  1988-06       Impact factor: 5.087

2.  Classification of normal colorectal mucosa and adenocarcinoma by morphometry.

Authors:  P W Hamilton; D C Allen; P C Watt; C C Patterson; J D Biggart
Journal:  Histopathology       Date:  1987-09       Impact factor: 5.087

3.  Histologic and colonoscopic assessment of disease extension in ulcerative colitis.

Authors:  C H Florén; C Benoni; R Willén
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

4.  A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis.

Authors:  V Binder
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

5.  What is colitis? Statistical approach to distinguishing clinically important inflammatory change in rectal biopsy specimens.

Authors:  D Jenkins; A Goodall; K Drew; B B Scott
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

6.  A controlled randomized trial of budesonide versus prednisolone retention enemas in active distal ulcerative colitis.

Authors:  A Danielsson; G Hellers; E Lyrenäs; R Löfberg; A Nilsson; O Olsson; S A Olsson; T Persson; L Salde; J Naesdal
Journal:  Scand J Gastroenterol       Date:  1987-10       Impact factor: 2.423

7.  Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial.

Authors:  C J Mulder; G N Tytgat; E H Wiltink; H J Houthoff
Journal:  Scand J Gastroenterol       Date:  1988-10       Impact factor: 2.423

8.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

Authors:  D Rachmilewitz
Journal:  BMJ       Date:  1989-01-14

9.  Morphometrical analysis in ulcerative colitis with dysplasia and carcinoma.

Authors:  D C Allen; P W Hamilton; P C Watt; J D Biggart
Journal:  Histopathology       Date:  1987-09       Impact factor: 5.087

10.  Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.

Authors:  S A Riley; V Mani; M J Goodman; M E Herd; S Dutt; L A Turnberg
Journal:  Gastroenterology       Date:  1988-06       Impact factor: 22.682

View more
  2 in total

1.  Diagnostic difficulty arising from rectal recovery in ulcerative colitis.

Authors:  T S Levine; M Tzardi; S Mitchell; C Sowter; A B Price
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

2.  A morphometric study of histological variations during cellular differentiation of normal human colorectal epithelium.

Authors:  G L Tipoe; F H White; C J Pritchett
Journal:  J Anat       Date:  1992-10       Impact factor: 2.610

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.